Subjects: DOENÇAS RETINIANAS, ELETRORRETINOGRAFIA, CÉLULAS-TRONCO
ABNT
SIQUEIRA, Rubens C. et al. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina, v. 31, n. 6, p. 1207-1214, 2011Tradução . . Disponível em: https://doi.org/10.1097/IAE.0b013e3181f9c242. Acesso em: 02 nov. 2024.APA
Siqueira, R. C., Messias, A. M. V., Voltarelli, J. C., Scott, I. U., & Jorge, R. (2011). Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina, 31( 6), 1207-1214. doi:10.1097/IAE.0b013e3181f9c242NLM
Siqueira RC, Messias AMV, Voltarelli JC, Scott IU, Jorge R. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial [Internet]. Retina. 2011 ; 31( 6): 1207-1214.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1097/IAE.0b013e3181f9c242Vancouver
Siqueira RC, Messias AMV, Voltarelli JC, Scott IU, Jorge R. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial [Internet]. Retina. 2011 ; 31( 6): 1207-1214.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1097/IAE.0b013e3181f9c242